Results 181 to 190 of about 268,961 (366)

The role of the new oral anticoagulants in the treatment of coronary disease

open access: yesRevista Colombiana de Cardiología, 2016
Hernando del Portillo   +3 more
doaj   +1 more source

A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract This small phase 1C, open‐label, single ascending dose study evaluated the safety, tolerability, and pharmacokinetics (PKs) of DM199, a recombinant form of human tissue kallikrein‐1 (KLK1). A small sample size of both healthy subjects and hypertensive adults recently taking angiotensin‐converting enzyme inhibitors was studied. KLK1 has a known
Michael Giuffre   +3 more
wiley   +1 more source

Are we aware of a new atherosclerosis nomenclature?

open access: yesRevista Colombiana de Cardiología, 2017
Darío Echeverri
doaj   +1 more source

The Electrocardiographic and Hemodynamic Findings in Pulmonary Stenosis with Intact Ventricular Septum [PDF]

open access: bronze, 1963
James B. Bassingthwaighte   +4 more
openalex   +1 more source

Effects of Dimenhydrinate on Motor Behavior and Vascular Function: Possible Implications for the Field of Sports

open access: yesDrug Testing and Analysis, EarlyView.
Regarding cardiovascular effects, DMH decreased vascular reactivity to phenylephrine and acetylcholine. We observed that the combination of DPH and 8‐Cl‐T was identified as the responsible for increasing blood pressure and heart rate in the biological model used.
Jazmín Flores‐Monroy   +3 more
wiley   +1 more source

Asymptomatic severe aortic stenosis.¿Is it better to observe than to operate?

open access: yesRevista Colombiana de Cardiología, 2017
Juan H. del Portillo   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy